Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it
BackgroundLung adenocarcinoma patients are often found to have developed bone metastases at the time of initial diagnosis.With the continuous development of technology, we have successfully entered the era of immunotherapy.This study aimed to determine the efficacy of immunotherapy in lung adenocarcinoma patients with bone metastases (LABM) through